相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。9. Pharmacologic Approaches to Glycemic Treatment: Standards of Medical Care in Diabetes-2021
DIABETES CARE (2021)
Association of British Clinical Diabetologists and Renal Association guidelines on the detection and management of diabetes post solid organ transplantation
Tahseen A. Chowdhury et al.
DIABETIC MEDICINE (2021)
Management of post-transplant diabetes: immunosuppression, early prevention, and novel antidiabetics
Manfred Hecking et al.
TRANSPLANT INTERNATIONAL (2021)
OPTN/SRTR 2019 Annual Data Report: Kidney
A. Hart et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2021)
Renal transplantation outcomes in obese patients: a French cohort-based study
Y. Foucher et al.
BMC NEPHROLOGY (2021)
Trends in epidemiologic characteristics of end-stage renal disease from 2019 Korean Renal Data System (KORDS)
Yu Ah Hong et al.
KIDNEY RESEARCH AND CLINICAL PRACTICE (2021)
The Long-term Effects of Metformin on Patients With Type 2 Diabetic Kidney Disease
Soie Kwon et al.
DIABETES CARE (2020)
Metformin Use and Risk of All-Cause Mortality and Cardiovascular Events in Patients With Chronic Kidney Disease-A Systematic Review and Meta-Analysis
Yao Hu et al.
FRONTIERS IN ENDOCRINOLOGY (2020)
Does metformin do more benefit or harm in chronic kidney disease patients?
Marc E. De Broe et al.
KIDNEY INTERNATIONAL (2020)
Outcomes of end-stage renal disease patients on the waiting list for deceased donor kidney transplantation: A single-center study
Hong Jae Jeon et al.
KIDNEY RESEARCH AND CLINICAL PRACTICE (2019)
Methods for time-varying exposure related problems in pharmacoepidemiology: An overview
Laura Pazzagli et al.
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2018)
Metformin use in the first year after kidney transplant, correlates, and associated outcomes in diabetic transplant recipients: A retrospective analysis of integrated registry and pharmacy claims data
L. S. Vest et al.
CLINICAL TRANSPLANTATION (2018)
Metformin, A New Era for an Old Drug in the Treatment of Immune Mediated Disease?
Mark Schuiveling et al.
CURRENT DRUG TARGETS (2018)
Effect of post-transplant glycemic control on long-term clinical outcomes in kidney transplant recipients with diabetic nephropathy: A multicenter cohort study in Korea
Yong Chul Kim et al.
PLOS ONE (2018)
Metformin Suppresses Systemic Autoimmunity in Roquinsan/san Mice through Inhibiting B Cell Differentiation into Plasma Cells via Regulation of AMPK/mTOR/STAT3
Seon-Yeong Lee et al.
JOURNAL OF IMMUNOLOGY (2017)
Metformin and Inflammation: Its Potential Beyond Glucose-lowering Effect
Yoshifumi Saisho
ENDOCRINE METABOLIC & IMMUNE DISORDERS-DRUG TARGETS (2015)
Metformin Use in Kidney Transplant Recipients in the United States: An Observational Study
Jenise Stephen et al.
AMERICAN JOURNAL OF NEPHROLOGY (2014)
Effects of Obesity on Kidney Transplantation Outcomes: A Systematic Review and Meta-Analysis
Bruna B. Nicoletto et al.
TRANSPLANTATION (2014)
Novel views on new-onset diabetes after transplantation: development, prevention and treatment
Manfred Hecking et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2013)
The Role of Obesity in Kidney Transplantation Outcome
G. Grosso et al.
TRANSPLANTATION PROCEEDINGS (2012)
Should Metformin Be Our Antiglycemic Agent of Choice Post-transplantation?
A. Sharif
AMERICAN JOURNAL OF TRANSPLANTATION (2011)
New-onset diabetes after kidney transplantation:: Risk factors
Emilio Rodrigo et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2006)